173 related articles for article (PubMed ID: 8137962)
21. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
Ruchhoft EA; Elkind-Hirsch KE; Malinak R
Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
[TBL] [Abstract][Full Text] [Related]
22. LRF and TRF test during long-term danazol treatment: increase of the LH and FSH responses but decrease of the prolactin and TSH responses.
Leppäluoto J; Rönnberg L; Ylöstalo P
Acta Endocrinol (Copenh); 1983 Sep; 104(1):1-5. PubMed ID: 6414205
[TBL] [Abstract][Full Text] [Related]
23. [Continuous subcutaneous infusion of GnRH agonist: effective dosage in the treatment of endometriosis and its influence on the ovarian response to human menopausal gonadotropin].
Masaoka K; Kitazawa M; Watanabe H; Kumasaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):729-36. PubMed ID: 2504848
[TBL] [Abstract][Full Text] [Related]
24. The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women.
Couzinet B; Young J; Kujas M; Meduri G; Brailly S; Thomas JL; Chanson P; Schaison G
J Clin Endocrinol Metab; 1999 Nov; 84(11):4191-6. PubMed ID: 10566671
[TBL] [Abstract][Full Text] [Related]
25. Feedback effects of ovarian steroids on the hypothalamic-hypophyseal axis in the rabbit.
Pau KY; Orstead KM; Hess DL; Spies HG
Biol Reprod; 1986 Nov; 35(4):1009-23. PubMed ID: 3101757
[TBL] [Abstract][Full Text] [Related]
26. Responses of patients to different lots of human menopausal gonadotropins during controlled ovarian hyperstimulation.
Stone BA; Quinn K; Quinn P; Vargyas JM; Marrs RP
Fertil Steril; 1989 Nov; 52(5):745-52. PubMed ID: 2509251
[TBL] [Abstract][Full Text] [Related]
27. A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis.
Takeuchi H; Kobori H; Kikuchi I; Sato Y; Mitsuhashi N
J Obstet Gynaecol Res; 2000 Oct; 26(5):325-31. PubMed ID: 11147718
[TBL] [Abstract][Full Text] [Related]
28. Effect of estradiol on hypothalamic GnRH and pituitary and serum LH and FSH in ovariectomized pigs.
Cox NM; Britt JH
J Anim Sci; 1982 Oct; 55(4):901-8. PubMed ID: 6815152
[TBL] [Abstract][Full Text] [Related]
29. Monitoring treatment of central precocious puberty using basal luteinizing hormone levels and practical considerations for dosing with a 3-month leuprolide acetate formulation.
Lee PA; Luce M; Bacher P
J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1249-1257. PubMed ID: 27740929
[TBL] [Abstract][Full Text] [Related]
30. A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol.
Fraser IS; Shearman RP; Jansen RP; Sutherland PD
Aust N Z J Obstet Gynaecol; 1991 May; 31(2):158-63. PubMed ID: 1834049
[TBL] [Abstract][Full Text] [Related]
31. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women.
Gelety TJ; Pearlstone AC; Surrey ES
Fertil Steril; 1995 Dec; 64(6):1074-80. PubMed ID: 7589655
[TBL] [Abstract][Full Text] [Related]
32. Leuprolide acetate lowers circulating bioactive luteinizing hormone and testosterone concentrations during ovarian stimulation for oocyte retrieval.
Cedars MI; Surey E; Hamilton F; Lapolt P; Meldrum DR
Fertil Steril; 1990 Apr; 53(4):627-31. PubMed ID: 2108057
[TBL] [Abstract][Full Text] [Related]
33. Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol.
Tummon IS; Ali A; Pepping ME; Radwanska E; Binor Z; Dmowski WP
Fertil Steril; 1988 May; 49(5):792-6. PubMed ID: 3129312
[TBL] [Abstract][Full Text] [Related]
34. Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results.
Wheeler JM; Knittle JD; Miller JD
Am J Obstet Gynecol; 1992 Nov; 167(5):1367-71. PubMed ID: 1442992
[TBL] [Abstract][Full Text] [Related]
35. Decrease in the size of ovarian endometriomas during ovarian suppression in stage IV endometriosis. Role of preoperative medical treatment.
Rana N; Thomas S; Rotman C; Dmowski WP
J Reprod Med; 1996 Jun; 41(6):384-92. PubMed ID: 8799912
[TBL] [Abstract][Full Text] [Related]
36. [Medical treatment of endometriosis: comparative study of leuprolide acetate and danazol].
Palagiano A; Capuano V
Minerva Ginecol; 1994 Apr; 46(4):173-7. PubMed ID: 8065590
[TBL] [Abstract][Full Text] [Related]
37. Profound luteinizing hormone suppression after stopping the gonadotropin-releasing hormone-agonist leuprolide acetate.
Sungurtekin U; Jansen RP
Fertil Steril; 1995 Mar; 63(3):663-5. PubMed ID: 7851604
[TBL] [Abstract][Full Text] [Related]
38. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
Garibaldi LR; Aceto T; Weber C; Pang S
J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
[TBL] [Abstract][Full Text] [Related]
39. The effects of a long-acting progestin on the hypothalamic-pituitary-ovarian axis in women with normal menstrual cycles.
Poindexter AN; Dildy GA; Brody SA; Snabes MC; Brodyand SA
Contraception; 1993 Jul; 48(1):37-45. PubMed ID: 8403904
[TBL] [Abstract][Full Text] [Related]
40. Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback.
Rochira V; Zirilli L; Genazzani AD; Balestrieri A; Aranda C; Fabre B; Antunez P; Diazzi C; Carani C; Maffei L
Eur J Endocrinol; 2006 Oct; 155(4):513-22. PubMed ID: 16990650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
